14 days ago
REPL
AnalystsAllison BratzelAllison Bratzel's Stock Forecasts
AnalystsAllison Bratzel
Sectors:
Industries:
Analyst Ranking
Top 11%
#498 out of 4906 analysts
Average Return
+24.94%
Win Rate
65%20 out of 31
Risk vs Reward
Poor
Good
Allison Bratzel's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Inozyme Pharma IncINZY | +276.42% | $1.06 | $3.99 | 2025-03-11 - 2025-06-13 | Strong Buy |
Scholar Rock Holding CorpSRRK | +121.87% | $15.00 | $33.28 | 2024-03-26 - 2025-03-25 | Strong Buy |
Scholar Rock Holding CorpSRRK | +86.26% | $8.44 | $15.72 | 2023-04-03 - 2024-04-02 | Strong Buy |
Vectivbio Holding AgVECT | +77.37% | $9.50 | $16.85 | 2023-04-20 - 2023-07-07 | Strong Buy |
Argenx SeARGX | +76.16% | $354.13 | $623.82 | 2023-12-21 - 2024-12-20 | Strong Buy |
Allison Bratzel Analyst Color
Get additional color on Allison Bratzel's coverage of popular stocks
3 months ago
AKBA
7 months ago
ARGX
8 months ago
SRRK
a year ago
ROIV
2 years ago
ARGX
Allison Bratzel's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Replimune Group IncREPL | 2 | Strong Buy | $22.00 | +124.95% | Maintains | 14 days ago |
Tyra Biosciences IncTYRA | 1 | Strong Buy | $33.00 | +216.40% | Assumes | a month ago |
Ultragenyx Pharmaceutical IncRARE | 1 | Strong Buy | $115.00 | +206.75% | Maintains | 3 months ago |
Akebia Therapeutics IncAKBA | 1 | Strong Buy | $6.00 | +68.54% | Maintains | 3 months ago |
Inozyme Pharma IncINZY | 1 | Strong Buy | $23.00 | +476.44% | Maintains | 3 months ago |
Engene Holdings IncENGN | 1 | Strong Buy | $26.00 | +680.78% | Initiates Coverage On | 4 months ago |
Argenx SeARGX | 13 | Strong Buy | $725.00 | +25.46% | Maintains | 5 months ago |
Travere Therapeutics IncTVTX | 2 | Hold | $22.00 | +51.72% | Maintains | 7 months ago |
Rigel Pharmaceuticals IncRIGL | 2 | Hold | $23.00 | +12.09% | Maintains | 7 months ago |
Ionis Pharmaceuticals IncIONS | 1 | Strong Buy | $62.00 | +74.21% | Maintains | 7 months ago |
Scholar Rock Holding CorpSRRK | 3 | Strong Buy | $42.00 | +29.43% | Maintains | 8 months ago |
Roivant Sciences LtdROIV | 2 | Strong Buy | $22.00 | +94.35% | Maintains | a year ago |
Humacyte IncHUMA | 2 | Hold | $4.00 | N/A | Maintains | a year ago |
Solid Biosciences IncSLDB | 4 | Strong Buy | $20.00 | N/A | Upgrades | a year ago |
Abcellera Biologics IncABCL | 1 | Strong Buy | $20.00 | N/A | Assumes | 2 years ago |
Vectivbio Holding AgVECT | 1 | Strong Buy | $25.00 | N/A | Maintains | 2 years ago |
Incyte CorpINCY | 2 | Strong Buy | $100.00 | N/A | Maintains | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.